In fact, most of the instruments currently used with patients under age 60 were developed for older adults and then applied to younger adults. Because cognitive outcomes are increasingly recognized as important in treatment studies, the need for brief yet sensitive assessment tools is critical.Īlthough there are multiple brief cognitive screening instruments available for use with adults aged 60 and older for dementia screening ( Brodaty, Fay, Gibson, & Burns, 2006 Ismail, Rajji, & Shulman, 2010), few have been developed for use with a broader age range. In research settings, such as clinical trials, cognitive impairment often is an inclusion or an exclusion criterion, depending on the study purpose, and the need to identify appropriate study subjects is important for ensuring the best chance of detecting the targeted outcome or treatment effect. If present, cognitive dysfunction may negatively affect health outcomes as cognitively impaired patients may fail to remember (or remember incorrectly) important details about their condition, treatment regimen, and/or healthcare providers' recommendations they may also lack insight into the need for treatment ( Gaviria, Pliskin, & Kney, 2011 Han et al., 2011 Martinez-Aran et al., 2009 Valldeoriola et al., 2011 Zogg et al., 2010). In clinical settings, complaints of cognitive problems are common, particularly in older adults and individuals with psychiatric conditions. Screening for cognitive impairment is important in clinical and research settings. Results indicate the BCSE has diagnostic utility as a cognitive screening measure in a mixed clinical sample and is more sensitive at detecting cognitive impairment, particularly milder levels, than the MMSE.Ĭognitive screening, Dementia, Mild cognitive impairment Introduction The BCSE was more sensitive in all clinical groups, although at extremely low scores, the two tests displayed similar sensitivity. On both measures, the DEM group obtained significantly lower scores than the other two groups, and the CIND group scored significantly lower than the NCI group. One hundred and eighty-two healthy controls from the BCSE standardization sample served as a comparison group. One hundred and eighty-two patients underwent cognitive evaluation and were placed into three groups: dementia (DEM), cognitive impairment, no dementia (CIND), and no cognitive impairment (NCI). The study purpose was to compare the diagnostic utility of the Brief Cognitive Status Exam (BCSE) to that of the Mini-Mental State Examination (MMSE) and to develop equated scores to facilitate comparisons.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |